全文获取类型
收费全文 | 626篇 |
免费 | 22篇 |
国内免费 | 96篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 33篇 |
妇产科学 | 1篇 |
基础医学 | 56篇 |
口腔科学 | 19篇 |
临床医学 | 109篇 |
内科学 | 161篇 |
皮肤病学 | 7篇 |
神经病学 | 9篇 |
特种医学 | 110篇 |
外科学 | 30篇 |
综合类 | 35篇 |
预防医学 | 21篇 |
眼科学 | 4篇 |
药学 | 101篇 |
肿瘤学 | 40篇 |
出版年
2023年 | 3篇 |
2022年 | 1篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 6篇 |
2018年 | 3篇 |
2017年 | 4篇 |
2016年 | 6篇 |
2015年 | 4篇 |
2014年 | 9篇 |
2013年 | 24篇 |
2012年 | 31篇 |
2011年 | 19篇 |
2010年 | 29篇 |
2009年 | 25篇 |
2008年 | 20篇 |
2007年 | 67篇 |
2006年 | 23篇 |
2005年 | 33篇 |
2004年 | 11篇 |
2003年 | 13篇 |
2002年 | 7篇 |
2001年 | 15篇 |
2000年 | 6篇 |
1999年 | 9篇 |
1998年 | 41篇 |
1997年 | 38篇 |
1996年 | 29篇 |
1995年 | 29篇 |
1994年 | 27篇 |
1993年 | 38篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 25篇 |
1988年 | 24篇 |
1987年 | 15篇 |
1986年 | 16篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 4篇 |
1980年 | 10篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 7篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有744条查询结果,搜索用时 15 毫秒
51.
52.
大肠癌免疫组化表达与临床病理的关系 总被引:1,自引:0,他引:1
目的:探讨大肠癌CEA、P53、nm23、Ki-67、MRP免疫组化表达特点和相互关系,及其与临床病理的关系.方法:回顾性分析2003-01/2006-07我院收治的73例大肠癌患者的临床病理及随访资料,并对其石蜡标本采用免疫组化SP染色法检测CEA、P53、nm23、Ki-67、MRP,分析其免疫组化特点及其与临床病理之间的关系.结果:CEA、P53、nm23、Ki-67、MRP在大肠癌中的阳性表达率依次为82.2%、68.5%、75.3%、84.9%和64.4%.CEA、MRP与大肠癌患者的各因素无统计学差异.P53、Ki-67和nm23与肿瘤的Dukes分期和淋巴结转移有关, P53、Ki-67在Dukes C、D期的阳性表达率(依次为82.8%和100%1明显高于Dukes A、B期者(59.1%和75.0%)(P<0.05),而nm23在Dukes C、D期的阳性表达率(58.6%)明显低于Dukes A、B期者(86.4%)(P<0.05).CEA与nm23的表达呈明显的负相关(r=-0.296,P=0.011),而P53和Ki-67表达之间呈现明显的正相关(r= 0.308,P=0.008),其他各指标间的表达无相关性.nm23、P53和Ki-67与预后因素关系明显,nm23在生存期≥3 a患者的阳性表达率(92.9%)高于生存期<3 a者(71.2%)(P<0.05),而P53和Ki-67在生存期≥3 a患者的阳性表达率(依次为42.9%和64.3%)明显低于生存期<3 a者(74.6%和89.8%)(P<0.05).结论:P53、Ki-67和nm23的表达与大肠癌的侵袭转移和预后密切相关.CEA可能是大肠癌的侵袭转移的促进因素.MRP所引起的耐药机制是一个相对独立的机制.CEA、P53、nm23、Ki-67可作为判断大肠癌恶性程度、侵袭转移以及预后的指标. 相似文献
53.
E Dillwyn Williams Alexander Abrosimov Tatiana Bogdanova Evgeny P Demidchik Masahiro Ito Virginia LiVolsi Evgeny Lushnikov Juan Rosai Mikola D Tronko Anatoly F Tsyb Sarah L Vowler Geraldine A Thomas 《Thyroid》2008,18(8):847-852
BACKGROUND: The Chernobyl accident caused an unprecedented increase in papillary thyroid carcinoma (PTC) incidence with a surprisingly short latency and unusual morphology. We have investigated whether unexpected features of the PTC incidence after Chernobyl were radiation specific or influenced by iodine deficiency. METHODS: PTCs from children from Belarus, Ukraine, and the Russian Federation exposed to fallout from Chernobyl were compared with PTCs from children not exposed to radiation from the same countries, from England and Wales (E&W) and from Japan. The degree and type of differentiation, fibrosis, and invasion were quantified. RESULTS: There were no significant differences between PTCs from radiation-exposed children from Belarus, Ukraine, and the Russian Federation and PTCs from children from the same countries who were not exposed to radiation. Childhood PTCs from Japan were much more highly differentiated (p < 0.001), showed more papillary differentiation (p < 0.001) and were less invasive (p < 0.01) than "Chernobyl" tumors, while tumors from E&W generally showed intermediate levels of degree and type of differentiation and invasion. There was a marked difference between the sex ratios of children with PTCs who were radiation exposed and those who were not exposed (F:M exposed vs. unexposed 1.5:1 vs. 4.2:1; chi(2) = 7.90, p < or = 0.01005). CONCLUSIONS: The aggressiveness and morphological features of Chernobyl childhood PTCs are not associated with radiation exposure. The differences found between tumors from the Chernobyl area, E&W, and Japan could be influenced by many factors. We speculate that dietary iodine levels may have wide implications in radiation-induced thyroid carcinogenesis, and that iodine deficiency could increase incidence, reduce latency, and influence tumor morphology and aggressiveness. 相似文献
54.
Freeman A Hamid S Morris L Vowler S Rushbrook S Wight DG Coleman N Alexander GJ 《Journal of viral hepatitis》2003,10(5):345-350
Summary. To test the hypothesis that hepatitis C virus (HCV) might induce hepatocyte proliferation directly, thereby predisposing HCV carriers to cirrhosis and hepatocellular carcinoma, we have used a new method to identify proliferating hepatocytes, employing a novel monoclonal antibody to minichromosome maintenance (Mcm) proteins, essential components of the pre-replication complex. Antibody to Ki-67, a conventional marker of cell division, was also studied. Eighty-seven patients with chronic HCV infection and a broad spectrum of histological change were studied. Proliferation was observed rarely in hepatocytes from normal liver from healthy controls (always less than 0.01%). However, proliferating hepatocytes were detected in all HCV-infected patients and the proportion of hepatocytes expressing Mcm-2 (3–40%) always exceeded that expressing Ki-67 (1–14%) and correlated positively with increasing stage of fibrosis ( P = 0.0001) and viral replication ( P = 0.0004). There were weaker but significant associations between the proportion of hepatocytes expressing Mcm-2 and inflammatory indices including interface hepatitis, portal tract inflammation, lobular inflammation and steatosis. There was no association between the proportion of hepatocytes expressing Mcm-2 and age, gender or past alcohol consumption, but there was a weak association with current consumption of alcohol ( P = 0.0067). The proportion of Ki-67 hepatocytes did not correlate with any clinical, laboratory or histological parameter. Mcm-2 was also detected in bile duct cells, sinusoidal lining cells and infiltrating lymphocytes, but at low frequency. These data indicate first, that Mcm-2 is a more sensitive marker of hepatocyte proliferation than Ki-67, second that many hepatocytes in chronic HCV infection have entered the cell cycle and third, suggest that interference with the hepatocyte cell cycle might be an alternative approach to therapy. 相似文献
55.
Jarolim P; Rubin HL; Brabec V; Chrobak L; Zolotarev AS; Alper SL; Brugnara C; Wichterle H; Palek J 《Blood》1995,85(3):634-640
To elucidate the molecular basis of band 3 deficiency in a recently defined subset of patients with autosomal dominant hereditary spherocytosis (HS), we screened band 3 cDNA for single-strand conformation polymorphism (SSCP). In 5 of 17 (29%) unrelated HS subjects with band 3 deficiency, we detected substitutions R760W, R760Q, R808C, and R870W that were all coinherited with the HS phenotype. The involved arginines are highly conserved throughout evolution. To examine whether or not the product of the mutant allele is inserted into the membrane, we studied one HS subject who was doubly heterozygous for the R760Q mutation and the K56E (band 3sMEMPHIS) polymorphism that results in altered electrophoretic mobility of the band 3 Memphis proteolytic fragments. We detected only the band 3MEMPHIS in the erythrocyte membrane indicating that the protein product of the mutant, R760Q, band 3 allele is absent from the red blood cell membrane. These findings suggest that the R760Q substitution, and probably the other arginine subsitutions, produce band 3 deficiency either by precluding incorporation of the mutant protein into the red blood cell membrane or by leading to loss of mutant protein from differentiating erythroid precursors. 相似文献
56.
Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization 总被引:1,自引:2,他引:1
Cord blood is a potential source of hematopoietic stem cells for transplantation and is being used on a growing number of patients. However, there are concerns that cord blood might be contaminated with maternal cells that could lead to graft-versus-host disease. To ascertain the extent to which maternal cell contamination of cord blood occurs, we examined 49 cord blood samples from male babies for maternal cells by fluorescence in situ hybridization using probes to the X and Y chromosomes. A minimum of 1,000 nuclei were scored from each sample, and maternal cells were found in 7 of the 49 cord bloods, at levels ranging from 0.04% to 1.0%. In addition, in 39 and 27 of the cord blood samples, respectively, we examined the CD8+ and CD34+ cell populations for maternal cells. Maternal cells were found in 5 of the 39 CD8 fractions and in 1 of the 27 CD34 fractions, at levels similar to that found in the unfractionated cord blood. In sum, maternal cells were found in either the unseparated mononuclear fraction or the CD8 or CD34 fractions in 10 of the 49 cord blood samples (20%). These results show that maternal cells are present in a substantial number of cord bloods, and that some of these maternal cells are T cells. 相似文献
57.
Fernando L GonçalesJr Camila A Moma Aline G Vigani Adriana FCF Angerami Eduardo SL Gonçales Raquel Tozzo Maria HP Pavan Neiva SL Gonçales 《BMC infectious diseases》2010,10(1):212
Background
More than 50% of hepatitis C viruses (HCV)-infected patients do not respond to the classical Interferon (IFN)/Ribavirin (RBV) combination therapy. The aim of this study was to evaluate the efficacy of retreatment with Peg-Interferon alpha-2b (PEG-IFN alpha-2b) plus RBV, in patients with HCV, genotypes 1 or 3, who were non-responders to the previous standard treatment with IFN/RBV. 相似文献58.
59.
JEFF S. HEALEY M.D. M.Sc. LORNE J. GULA M.D. DAVID H. BIRNIE M.D. LAWRENCE STERNS M.D. STUART J. CONNOLLY M.D. JOHN SAPP M.D. EUGENE CRYSTAL M.D. CHRIS SIMPSON M.D. DEREK V. EXNER M.D. M.P.H. TERESA KUS M.D. FRANCOIS PHILIPPON M.D. GEORGE WELLS Ph.D. ANTHONY SL. TANG M.D. 《Journal of cardiovascular electrophysiology》2012,23(12):1313-1316
Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing. Introduction: The need to perform defibrillation testing (DT) at the time of implantable cardioverter defibrillator (ICD) insertion is controversial. In the absence of randomized trials, some regions now perform more than half of ICD implants without DT. Methods: During the last year of enrolment in the Resynchronization for Ambulatory Heart Failure Trial, a substudy randomized patients to ICD implantation with versus without DT. Results: Among 252 patients screened, 145 were enrolled; 75 randomized to DT and 70 to no DT. Patients were similar in terms of age (65.9 ± 9.3 years vs 67.9 ± 8.9 years); LVEF (24.7 ± 4.6% vs 23.6 ± 4.6%), QRS width (154.8 ± 23.5 vs 155.8 ± 23.6 ms), and history of atrial fibrillation (5% vs 6%). All 68 patients in the DT arm tested according to the protocol achieved a successful DT (≤25 J); 96% without requiring any system modification. No patient experienced perioperative stroke, myocardial infarction, heart failure (HF), intubation or unplanned ICU stay. The length of hospital stay was not prolonged in the DT group: 20.2 ± 26.3 hours versus 21.3 ± 23.0 hours, P = 0.79. One patient in the DT arm had a failed appropriate shock and no patient suffered an arrhythmic death. The composite of HF hospitalization or all‐cause mortality occurred in 10% of patients in the no‐DT arm and 19% of patients in the DT arm (HR = 0.53, 95% CI: 0.21–1.31, P = 0.14). Conclusions: In this randomized trial, perioperative complications, failed appropriate shocks, and arrhythmic death were all uncommon regardless of DT. There was a nonsignificant increase in the risk of death or HF hospitalization with DT. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1313‐1316, December 2012) 相似文献
60.
Please cite this paper as: Drummond GB and Vowler SL. Different Tests for a Difference: How do we do Research? Microcirculation 19: 188–191, 2012. 相似文献